Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,605.50
(
0.75%
)
US TECH 100
23,564.40
(
0.88%
)
Dow Jones
46,429.21
(
0.66%
)
Brent Oil
96.63
(
0.13%
)
Bitcoin
71,370.98
(
1.21%
)
News Focus
News Focus
Post# of 257278
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 186502

Thursday, 04/09/2015 9:40:19 AM

Thursday, April 09, 2015 9:40:19 AM

Post# of 257278
JNJ at EASL:

http://finance.yahoo.com/news/janssen-highlights-hepatitis-c-virus-080000232.html

Early-stage data on the investigational nucleotide analog polymerase inhibitors AL-335 and AL-516, which were recently obtained through Janssen’s acquisition of Alios BioPharma, will also be presented.

Not likely to cause a rush of investor excitement.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today